financetom
Business
financetom
/
Business
/
Reliance Jio launches 'All in One' plans. Check price and other details
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reliance Jio launches 'All in One' plans. Check price and other details
Oct 21, 2019 5:16 AM

Reliance Jio has launched “all-in-one” data plans, offering attractive prices on data recharges. A one-month plan by Jio is priced at Rs 222. It comes with 2 GB internet per day and free unlimited calling on the Jio network.

The two-month plan costs Rs 333 with the same benefits, while the three-month plan is priced at Rs 444.

Jio’s new plans offer better value for money over their existing plans. The earlier three-month plan cost Rs 448 but it has now come down to Rs 444, while the two-month plan has come down to Rs 333 from Rs 396 earlier.

Reliance Jio data plans

Disclosure:

Reliance Industries, the promoter of Reliance Jio, also controls Network18, the parent company of CNBCTV18.com.

First Published:Oct 21, 2019 2:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--L3Harris Technologies Lifts Full-Year 2024 Adjusted Segment Operating Margin Guidance to 15.5%
--L3Harris Technologies Lifts Full-Year 2024 Adjusted Segment Operating Margin Guidance to 15.5%
Oct 25, 2024
04:44 PM EDT, 10/24/2024 (MT Newswires) -- Price: 254.00, Change: +9.83, Percent Change: +4.03 ...
Marinus Pharmaceuticals Shares Plunge as Phase 3 Trial of Ganaxolone Fails to Meet Goal; Plans to Cut Costs, Explore Alternatives
Marinus Pharmaceuticals Shares Plunge as Phase 3 Trial of Ganaxolone Fails to Meet Goal; Plans to Cut Costs, Explore Alternatives
Oct 25, 2024
03:08 PM EDT, 10/24/2024 (MT Newswires) -- Marinus Pharmaceuticals ( MRNS ) shares plunged nearly 82% in recent Thursday trading after the company said its phase 3 trial of oral ganaxolone failed to meet its main goal and announced plans to reduce costs and explore alternatives for the business. Marinus was studying the drug as a treatment for seizures associated...
US court blocks Tapestry's $8.5 billion acquisition of rival Capri
US court blocks Tapestry's $8.5 billion acquisition of rival Capri
Oct 25, 2024
NEW YORK, Oct 24 (Reuters) - A U.S. judge blocked the pending $8.5 billion merger of U.S. handbag and accessories maker Tapestry and Capri on Thursday, a victory for the U.S. Federal Trade Commission in an industry where merger challenges are rare. The FTC argued at an eight-day trial in New York that the merger would eliminate fierce head-to-head competition...
US State Dept OKs possible sale of TOW missiles to Saudi Arabia, Pentagon says
US State Dept OKs possible sale of TOW missiles to Saudi Arabia, Pentagon says
Oct 25, 2024
WASHINGTON, Oct 24 (Reuters) - The U.S. State Department has approved the potential sale of TOW missiles to Saudi Arabia for an estimated cost of $440 million, the Pentagon said on Thursday. The principal contractor will be RTX Corp ( RTX ), the Pentagon said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved